AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
This is a single-center, prospective, stratified 1:1 parallel-group randomized superiority diagnostic trial at The First Hospital of Jilin University. Eligible emergency patients aged โฅ18 who received routine thoraco-abdominal non-contrast CT were randomly assigned to two groups. The experimental group adopted a self-developed vision-language large model (powER) for auxiliary CT interpretation, while the control group received standard radiological reading without AI assistance. All participants completed standardized 60-day clinical follow-up to obtain clinical gold-standard outcomes. The primary objective is to compare the diagnostic performance of the AI model versus conventional radiology interpretation for multiple acute thoraco-abdominal emergency lesions.
Sign in to get the eligibility rules as simple questions to take to your doctor.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy